Fatigue¶
Chapter 25 | Part 2: Cardinal Manifestations and Presentation of Diseases
KEY CLINICAL POINTS¶
- Fatigue is defined as difficulty initiating or maintaining voluntary mental or physical activity, distinct from muscle weakness, somnolence, and dyspnea
- Psychiatric disease (depression, anxiety, somatoform disorders) accounts for symptoms in >75% of patients with unexplained chronic fatigue
- Laboratory testing identifies the cause in only ~5% of cases; extensive unfocused testing should be avoided
- A detailed neuropsychiatric and mental status evaluation has the highest diagnostic yield (75-80% of cases)
- Treatment focuses on addressing underlying disorders, with cognitive-behavioral therapy and graded exercise therapy showing benefit in chronic fatigue syndrome
1. DEFINITION & OVERVIEW¶
Fatigue is one of the most common symptoms in clinical medicine, representing a prominent manifestation of numerous systemic, neurologic, and psychiatric syndromes. However, a precise cause will not be identified in a substantial minority of patients. Fatigue refers to the subjective experience of physical and mental weariness, sluggishness, low energy, and exhaustion. In clinical medicine, fatigue is most practically defined as difficulty initiating or maintaining voluntary mental or physical activity. Fatigue is usually brought to medical attention only when it is of unclear cause, fails to remit, or the severity is out of proportion with what would be expected for the associated trigger.
1.1 Distinguishing Fatigue from Related Symptoms¶
Fatigue must be distinguished from several related but distinct symptoms: - Muscle weakness: A reduction of neuromuscular power; most patients complaining of fatigue are not truly weak when direct muscle power is tested - Somnolence: Sleepiness in the context of disturbed sleep-wake physiology - Dyspnea on exertion: Breathlessness with activity Patients may use the word "fatigue" to describe any of these symptoms, requiring careful clinical differentiation.
1.2 Clinical Approach Goals¶
The task facing clinicians when a patient presents with fatigue is to: 1. Identify the underlying cause 2. Develop a therapeutic alliance 3. Spare patients expensive and fruitless diagnostic workups 4. Steer patients toward effective therapy
2. EPIDEMIOLOGY¶
Variability in the definitions of fatigue and survey instruments used in different studies makes it difficult to arrive at precise figures about the global burden of fatigue.
2.1 Prevalence Data¶
- Point prevalence: 6.7% (U.S. general population, NIMH survey)
- Lifetime prevalence: 25% (U.S. general population, NIMH survey)
- Primary care clinics (Europe and U.S.): 10-25% of patients endorse prolonged (>1 month) or chronic (>6 months) fatigue
- Community survey of women in India: 12% reported chronic fatigue
- Myalgic encephalomyelitis/chronic fatigue syndrome (as defined by CDC): Low prevalence
2.2 Clinical Context¶
In primary care settings, only a minority of patients with prolonged or chronic fatigue seek medical attention primarily for this symptom. Fatigue is more commonly a secondary complaint accompanying other conditions.
3. ETIOLOGY & DIFFERENTIAL DIAGNOSIS¶
The differential diagnosis of fatigue is extensive, encompassing psychiatric, neurologic, systemic, infectious, pharmacologic, and idiopathic causes.
Differential Diagnosis of Fatigue by Category¶
| Category | Conditions | Key Features |
|---|---|---|
| Psychiatric | Depression, anxiety, somatoform disorders | Present in >75% of unexplained chronic fatigue |
| Neurologic | MS, Parkinson's, ALS, post-stroke, TBI | MS: affects ~90%; distinguish from weakness |
| Sleep Disorders | Obstructive sleep apnea | Snoring, obesity; requires polysomnography |
| Endocrine | Hypothyroid, hyperthyroid, adrenal insufficiency, DM | Associated systemic symptoms guide diagnosis |
| Hepatorenal | Chronic liver failure, CKD | >80% hemodialysis patients affected |
| Metabolic | Obesity, malnutrition, low vitamin D | Physical inactivity contributory |
| Infectious | TB, HIV, hepatitis, endocarditis, post-viral | ~1/3 COVID-19 patients have fatigue ‡3 months |
| Pharmacologic | Antidepressants, opiates, beta blockers, others | Drug withdrawal, alcohol also causative |
| Cardiopulmonary | CHF, COPD | Major impact on quality of life |
| Malignancy | Occult cancer, cancer-related fatigue | 40% at diagnosis, >80% during course |
| Category | Conditions | Key Features |
|---|---|---|
| Hematologic | Anemia, low ferritin | Iron replacement may help even without anemia |
| Inflammatory | SLE, RA, IBD, vasculitis, sarcoidosis | Not usually isolated symptom |
| Idiopathic | ME/CFS, fibromyalgia, Gulf-War syndrome | Syndromic definitions with specific criteria |
3.1 Psychiatric Disease¶
Fatigue is a common somatic manifestation of major psychiatric syndromes: - Depression - Anxiety disorders - Somatoform disorders Psychiatric symptoms are reported in more than three-quarters (>75%) of patients with unexplained chronic fatigue. Even in patients with systemic or neurologic disorders where fatigue is independently recognized, comorbid psychiatric disease may still be an important contributor.
3.2 Neurologic Disease¶
Patients with fatigue often report feeling weak, but objective muscle weakness is rarely discernible upon examination. Key neurologic causes include: - Multiple Sclerosis (MS): Fatigue affects nearly 90% of patients; can persist between MS attacks and does not necessarily correlate with MRI disease activity - Parkinson's disease: Increasingly identified as a troublesome feature - Amyotrophic lateral sclerosis (ALS): Common associated symptom - Central nervous system dysautonomias: Associated with fatigue - Post-stroke fatigue: Well-described but poorly understood entity with widely varying prevalence - Migraine: Episodic fatigue can be a premonitory symptom - Traumatic brain injury: Frequent consequence, often occurring with depression and sleep disorders If weakness is found, it must be localized to the central nervous system, peripheral nervous system, neuromuscular junction, or muscle. Fatigability of muscle power is a cardinal manifestation of neuromuscular disorders such as myasthenia gravis, distinguished by clinically evident diminution of force upon repeated contraction.
3.3 Sleep Disorders¶
Obstructive sleep apnea is an important cause of excessive daytime sleepiness with fatigue. Investigation with overnight polysomnography is indicated, particularly in those with: - Prominent snoring - Obesity - Other predictors of obstructive sleep apnea The contribution of cumulative sleep deprivation common in modern society to clinically apparent fatigue is not known.
3.4 Endocrine Disorders¶
- Hypothyroidism: Fatigue sometimes with true muscle weakness; associated with hair loss, dry skin, cold intolerance, constipation, weight gain
- Hyperthyroidism: Fatigue associated with heat intolerance, sweating, palpitations
- Adrenal insufficiency: Unexplained fatigue as primary/prominent symptom, often with anorexia, weight loss, nausea, myalgias, arthralgias; may have hyponatremia, hyperkalemia, hyperpigmentation
- Hypercalcemia: Mild causes vague fatigue; severe causes lethargy, stupor, coma
- Diabetes mellitus: Both hypoglycemia and hyperglycemia cause lethargy with confusion; Type 1 diabetes associated with fatigue independent of glucose levels
- Cushing's disease: Associated with fatigue
- Hypoaldosteronism: Associated with fatigue
- Hypogonadism: Associated with fatigue
- Low vitamin D status: Associated with fatigue
3.5 Liver and Kidney Disease¶
- Chronic liver failure: Can cause fatigue
- Chronic kidney disease: Can cause fatigue; >80% of hemodialysis patients complain of fatigue, making it one of the most common symptoms in CKD
3.6 Obesity and Physical Inactivity¶
Obesity: - Associated with fatigue and sleepiness independent of obstructive sleep apnea - Bariatric surgery patients experience improvement in daytime sleepiness sooner than expected if solely from weight loss/resolution of sleep apnea - Contributing factors: physical inactivity, diabetes, depression Physical Inactivity: - Associated with fatigue - Increasing physical activity can improve fatigue in some patients
3.7 Malnutrition¶
- Fatigue can be a presenting feature of malnutrition
- Nutritional status may be an important comorbidity and contributor to fatigue in other chronic illnesses, including cancer-associated fatigue
3.8 Infection¶
Both acute and chronic infections commonly cause fatigue as part of the broader infectious syndrome. Evaluation should be guided by history, physical examination, and risk factors with particular attention to: - Tuberculosis - HIV - Chronic hepatitis - Endocarditis Infectious mononucleosis: May cause prolonged fatigue persisting weeks to months following acute illness, but EBV is only very rarely the cause of unexplained chronic fatigue. Postinfectious fatigue occurs following various acute infections: - SARS-CoV-1 - SARS-CoV-2 (COVID-19): Almost one-third of patients report fatigue ≥ 3 months following diagnosis - Dengue - Ebola virus
3.9 Drugs and Medications¶
Many medications, drugs, drug withdrawal, and chronic alcohol use can lead to fatigue. Medications more likely to cause fatigue: - Antidepressants - Antipsychotics - Anxiolytics - Opiates - Antispasticity agents - Antiseizure agents - Beta blockers
3.10 Cardiovascular and Pulmonary Disorders¶
- Congestive heart failure: Fatigue is one of the most taxing symptoms, negatively affecting quality of life
- Chronic obstructive pulmonary disease: Fatigue significantly affects quality of life In a population-based cohort study (Norfolk, UK), fatigue was associated with increased hazard of all-cause mortality, particularly for cardiovascular disease-related deaths.
3.11 Malignancy¶
- Fatigue, particularly with unexplained weight loss, can indicate occult malignancy
- Cancer is rarely identified in patients with unexplained chronic fatigue without other signs/symptoms
- Cancer-related fatigue: Experienced by 40% at diagnosis and >80% at some point in disease course
3.12 Hematologic Disorders¶
- Chronic or progressive anemia: May present with fatigue, sometimes with exertional tachycardia and breathlessness
- Anemia may contribute to fatigue in chronic illness
- Low serum ferritin without anemia: May cause fatigue reversible with iron replacement
3.13 Immune-Mediated Disorders¶
Fatigue is a prominent complaint in many chronic inflammatory disorders, but is not usually an isolated symptom: - Systemic lupus erythematosus - Polymyalgia rheumatica - Rheumatoid arthritis - Inflammatory bowel disease - ANCA-associated vasculitis - Sarcoidosis - Sjögren's syndrome - Primary immunodeficiency diseases
3.14 Pregnancy¶
Fatigue is very commonly reported by women during all stages of pregnancy and postpartum.
3.15 Disorders of Unclear Cause¶
- Myalgic encephalomyelitis (ME)/Chronic fatigue syndrome (CFS): Incorporates chronic fatigue as part of syndromic definition when present with other criteria
- Fibromyalgia: Chronic fatigue part of syndromic definition with additional criteria
- Chronic multisymptom illness (Gulf-War syndrome): Prominent fatigue; most commonly observed in veterans of 1991 Gulf War conflict
- Idiopathic chronic fatigue: Unexplained chronic fatigue without enough features to meet ME/CFS diagnostic criteria
4. CLINICAL FEATURES¶
The clinical presentation of fatigue varies based on underlying etiology, but certain features help characterize the symptom and guide evaluation.
4.1 Quality and Pattern¶
Key characteristics to assess: - Quality of fatigue (physical vs. mental vs. combined) - Pattern (constant vs. fluctuating) - Time course (acute vs. prolonged [>1 month] vs. chronic [>6 months]) - Associated symptoms - Alleviating factors - Impact on daily functioning
4.2 Red Flag Symptoms¶
Symptoms raising suspicion for occult infection or malignancy: - Fever - Chills - Night sweats - Weight loss
4.3 Physical Examination Findings¶
Breakaway weakness: Patients with fatigue may have difficulty sustaining effort against resistance, with full power generated briefly before suddenly giving way. This is distinguished from: - Pyramidal/lower motor unit weakness: Resistance overcome smoothly and steadily; full power never generated - Fatigable weakness: Power full initially but weak upon repeat testing without rest; indicates neuromuscular transmission problem (e.g., myasthenia gravis); never has sudden breakaway quality
5. INVESTIGATIONS & DIAGNOSIS¶
The diagnostic approach to fatigue emphasizes history and physical examination over laboratory testing, as extensive unfocused investigation has low yield and may lead to unnecessary follow-up.
Recommended Laboratory Screening for Unexplained Chronic Fatigue¶
| Test | Purpose/Condition Screened |
|---|---|
| Complete blood count with differential | Anemia, infection, malignancy |
| Electrolytes (Na, K, Ca) | Electrolyte abnormalities, hypercalcemia |
| Glucose | Diabetes mellitus, hypoglycemia |
| Renal function (BUN, creatinine) | Chronic kidney disease |
| Liver function tests | Chronic liver disease |
| Thyroid function (TSH) | Hypothyroidism, hyperthyroidism |
| HIV testing (consider) | HIV infection |
| Test | Purpose/Condition Screened |
|---|---|
| Adrenal function (consider) | Adrenal insufficiency |
| ESR (per ME/CFS guidelines) | Inflammatory conditions (nonspecific) |
5.1 History Taking¶
A detailed history should address: - Whether "fatigue" is the appropriate designation for symptoms - Acute vs. chronic nature - Primarily mental, physical, or combined impairment - Distinction from sleepiness, dyspnea on exertion, exercise intolerance, muscle weakness - Constitutional symptoms (fever, chills, night sweats, weight loss) - Complete medication review (prescription, OTC, herbal, recreational drugs, alcohol) - Circumstances and triggers surrounding symptom onset - Social history: life stressors, adverse experiences, work hours, social support, domestic affairs, intimate partner violence screening - Sleep habits and sleep hygiene
5.2 Physical Examination¶
Examination should include: 1. Detailed mental status examination with attention to depression and anxiety symptoms 2. Formal neurologic examination to determine presence of objective muscle weakness 3. General physical examination screening for: - Cardiopulmonary disease - Malignancy - Lymphadenopathy - Organomegaly - Infection - Liver failure - Kidney disease - Malnutrition - Endocrine abnormalities - Connective tissue disease 4. Tender point assessment if widespread musculoskeletal pain present (fibromyalgia)
5.3 Diagnostic Yield of Evaluation Components¶
- General physical examination: Elucidates cause in only ~2% of unexplained chronic fatigue cases
- Detailed neuropsychiatric/mental status evaluation: Reveals potential explanation in up to 75-80% of patients
- Laboratory testing: Identifies cause in only ~5% of cases
5.4 Laboratory Testing¶
Beyond standard screening tests, laboratory evaluation should be guided by history and physical examination. Recommended screening tests: - Complete blood count with differential (anemia, infection, malignancy) - Electrolytes (sodium, potassium, calcium) - Glucose - Renal function - Liver function - Thyroid function Consider adding: - HIV testing - Adrenal function testing - Erythrocyte sedimentation rate (ESR) - per ME/CFS guidelines, but nonspecific unless very high
5.5 Tests to Avoid¶
Extensive unfocused testing should be avoided as it leads to: - Incidental findings requiring explanation - Unnecessary follow-up investigation - Patient anxiety Specifically not recommended routinely: - Routine ANA screening: Unlikely to be informative in isolation; frequently positive at low titers in healthy adults - Whole-body imaging scans: Usually not indicated; reveal unrelated incidental findings prolonging workup Note: EMG with nerve conduction studies can be helpful if presence/absence of weakness cannot be determined on physical examination.
6. MANAGEMENT & TREATMENT¶
Treatment of fatigue prioritizes addressing underlying disorders, with supportive therapies for refractory cases.
Treatment Approaches for Fatigue¶
| Treatment | Indications | Evidence/Notes |
|---|---|---|
| Address underlying disorder | All patients | First priority; may be curative or palliative |
| Antidepressants | Fatigue with depression symptoms | Most effective as multimodal approach; can cause fatigue |
| Cognitive-behavioral therapy | ME/CFS, cancer-related fatigue | Demonstrated benefit in trials |
| Graded exercise therapy | ME/CFS, cancer, MS, diabetes | Modest benefit; maintained at 2.5 years |
| Psychostimulants | Select cases with sleepiness | Generally unhelpful in trials for TBI, PD, cancer, MS |
| Vitamin D replacement | Low vitamin D status | May lead to improvement |
6.1 General Principles¶
First priority: Address underlying disorder(s) - Curative in select contexts - Palliative in others Important considerations: - In many chronic illnesses, fatigue may be refractory to traditional disease-modifying therapies - Evaluate for other potential contributors as cause may be multifactorial - Development of more effective therapy is hampered by limited knowledge of the biologic basis of fatigue
6.2 Pharmacologic Treatment¶
Antidepressants: - May be helpful when symptoms of depression are present - Generally most effective as part of multimodal approach - Can also cause fatigue and should be discontinued if not clearly effective Psychostimulants (amphetamines, modafinil, armodafinil): - Can increase alertness and concentration - Reduce excessive daytime sleepiness - May help fatigue symptoms in minority of patients - Generally proven unhelpful in randomized trials for: - Post-traumatic brain injury - Parkinson's disease - Cancer - Multiple sclerosis Vitamin D replacement: - May improve fatigue in patients with low vitamin D status
6.3 Non-Pharmacologic Treatment¶
Cognitive-Behavioral Therapy (CBT): - Demonstrated helpful in ME/CFS - Beneficial in cancer-associated fatigue Graded Exercise Therapy: - Physical exercise (most typically walking) gradually increased - Attention to target heart rates to avoid overexertion - UK studies showed modest improvement in: - Walking times - Self-reported fatigue measures - Benefits compared to standard medical care - Benefits maintained after median 2.5 years follow-up Exercise has also demonstrated benefit for fatigue related to: - Cancer - Multiple sclerosis - Diabetes
6.4 Building Therapeutic Alliance¶
A complete physical examination: - Demonstrates serious and systematic approach to patient's complaint - Helps build trust and therapeutic alliance - Important even when diagnostic yield is low Frequent clinical follow-up is preferred over extensive testing.
7. PROGNOSIS & COMPLICATIONS¶
Prognosis of fatigue depends entirely on the underlying cause and response to treatment.
7.1 Mortality Associations¶
In a population-based cohort study (Norfolk, UK): - Fatigue was associated with increased hazard of all-cause mortality in the general population - Particularly associated with cardiovascular disease-related deaths
7.2 Quality of Life Impact¶
Fatigue significantly impacts quality of life in chronic conditions, particularly: - Congestive heart failure - Chronic obstructive pulmonary disease - Cancer - Multiple sclerosis - Chronic kidney disease
8. SPECIAL CONSIDERATIONS¶
8.1 Post-Infectious Fatigue¶
A substantial minority of patients who have recovered from certain infections experience persistent fatigue: - SARS-CoV-1 - SARS-CoV-2 (COVID-19): ~1/3 report fatigue ≥ 3 months post-diagnosis - Dengue - Ebola virus - Infectious mononucleosis: Prolonged fatigue weeks to months after acute illness
8.2 Pregnancy¶
Fatigue is very commonly reported during: - All stages of pregnancy - Postpartum period
8.3 Veterans¶
Chronic multisymptom illness (Gulf-War syndrome): - Prominent fatigue - Most commonly observed in veterans of 1991 Gulf War conflict - Not exclusively limited to this population
8.4 Cancer Patients¶
Cancer-related fatigue: - Experienced by 40% at diagnosis - Affects >80% at some point during disease course - May be refractory to disease-modifying therapies - Multifactorial contributors should be evaluated - CBT and exercise therapy may help
9. KEY POINTS & CLINICAL PEARLS¶
Summary: Approach to the Patient with Fatigue¶
| Step | Action | Key Points |
|---|---|---|
| 1 | Define the symptom | Distinguish from weakness, somnolence, dyspnea |
| 2 | Characterize | Quality, pattern, time course, acute vs chronic |
| 3 | Detailed history | Medications, sleep, social factors, psychiatric screen |
| 4 | Physical examination | Mental status, neurologic exam, general exam |
| 5 | Focused labs | CBC, electrolytes, glucose, renal, liver, thyroid |
| 6 | Identify cause | Treat underlying disorder(s) |
| 7 | Supportive therapy | CBT, graded exercise if indicated |
| 8 | Follow-up | Frequent clinical follow-up preferred over more testing |
9.1 Diagnostic Pearls¶
- Psychiatric disease accounts for symptoms in >75% of unexplained chronic fatigue - always screen for depression and anxiety
- Detailed neuropsychiatric evaluation has highest yield (75-80%) vs. general physical exam (~2%) or labs (~5%)
- Most patients complaining of fatigue are not truly weak when muscle power is tested
- Breakaway weakness (sudden give-way) differs from pyramidal weakness (smooth, steady) and fatigable weakness (myasthenia)
- Extensive unfocused testing often harmful - leads to incidental findings and unnecessary workup
9.2 Treatment Pearls¶
- Always address underlying disorders first - may be curative
- Fatigue may be multifactorial even when primary cause is identified
- Antidepressants can both treat and cause fatigue - discontinue if not clearly effective
- Psychostimulants generally unhelpful in randomized trials for most causes of fatigue
- CBT and graded exercise have best evidence for ME/CFS and cancer-related fatigue
- Building therapeutic alliance through thorough evaluation is itself therapeutic
9.3 Common Pitfalls to Avoid¶
- Confusing fatigue with weakness, somnolence, or dyspnea
- Ordering extensive unfocused laboratory and imaging studies
- Failing to screen for depression and anxiety
- Missing medication-induced fatigue
- Overlooking sleep disorders, especially obstructive sleep apnea
- Failing to reassess for new contributing factors in chronic fatigue
- EBV serology for unexplained chronic fatigue (very rarely causative)